Andrew Reardon
Chief Legal Officer at Ligand Pharmaceuticals
About
Ligand's Chief Legal Officer since 2022, previously a VP and Special Counsel at the company. He spent over a decade as CLO of HealthCare Royalty Partners and earlier practiced corporate law at Willkie Farr & Gallagher.
Colleagues at Ligand Pharmaceuticals
James Pipkin
Vice President, New Product Development at Ligand Pharmaceuticals
Karen Reeves
Senior Vice President, Investments and Head of Clinical Strategy at Ligand Pharmaceuticals
Keith Marschke
Senior Vice President, Biology and Scientific Affairs at Ligand Pharmaceuticals
Lauren Hay
Vice President, Portfolio Strategy and Investments at Ligand Pharmaceuticals
Lee Brown
Vice President, Investments and Business Development at Ligand Pharmaceuticals
Marjorie Fackovec
Head of People Operations at Ligand Pharmaceuticals
Michael Vigilante
Vice President, Investments and Business Development at Ligand Pharmaceuticals
Paul J. Hadden
Senior Vice President, Investments and Business Development at Ligand Pharmaceuticals